Correlation Between IShares Genomics and SPDR Galaxy
Can any of the company-specific risk be diversified away by investing in both IShares Genomics and SPDR Galaxy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Genomics and SPDR Galaxy into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Genomics Immunology and SPDR Galaxy Hedged, you can compare the effects of market volatilities on IShares Genomics and SPDR Galaxy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Genomics with a short position of SPDR Galaxy. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Genomics and SPDR Galaxy.
Diversification Opportunities for IShares Genomics and SPDR Galaxy
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between IShares and SPDR is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding iShares Genomics Immunology and SPDR Galaxy Hedged in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SPDR Galaxy Hedged and IShares Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Genomics Immunology are associated (or correlated) with SPDR Galaxy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SPDR Galaxy Hedged has no effect on the direction of IShares Genomics i.e., IShares Genomics and SPDR Galaxy go up and down completely randomly.
Pair Corralation between IShares Genomics and SPDR Galaxy
Given the investment horizon of 90 days iShares Genomics Immunology is expected to under-perform the SPDR Galaxy. But the etf apears to be less risky and, when comparing its historical volatility, iShares Genomics Immunology is 2.6 times less risky than SPDR Galaxy. The etf trades about -0.03 of its potential returns per unit of risk. The SPDR Galaxy Hedged is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 3,193 in SPDR Galaxy Hedged on August 25, 2024 and sell it today you would earn a total of 562.00 from holding SPDR Galaxy Hedged or generate 17.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
iShares Genomics Immunology vs. SPDR Galaxy Hedged
Performance |
| Timeline |
| iShares Genomics Imm |
| SPDR Galaxy Hedged |
IShares Genomics and SPDR Galaxy Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with IShares Genomics and SPDR Galaxy
The main advantage of trading using opposite IShares Genomics and SPDR Galaxy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Genomics position performs unexpectedly, SPDR Galaxy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SPDR Galaxy will offset losses from the drop in SPDR Galaxy's long position.| IShares Genomics vs. Global X Genomics | IShares Genomics vs. iShares Cybersecurity and | IShares Genomics vs. iShares Self Driving EV |
| SPDR Galaxy vs. SPDR Kensho New | SPDR Galaxy vs. Global X FinTech | SPDR Galaxy vs. iShares Genomics Immunology | SPDR Galaxy vs. Aquagold International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |